Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-09

Clinical Trial Update: Tirofiban for Patients Treated With Alteplase [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on tirofiban for patients treated with alteplase in ischemic stroke (Phase 2/3), terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tirofiban (tirofiban)

Snippet

Sponsor: Capital Medical University | Conditions: Ischemic Stroke | Phase 2, Phase 3 | Status: TERMINATED